The Value of the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP) for those with Neurofibromatosis (NF)

The Value of the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP) for those with Neurofibromatosis (NF)

Friday January 11, 201911:00am-12:00pm2212 Rayburn House Office Building

Dear Colleague,

Currently, there are no effective treatments and no cure for neurofibromatosis (NF), a genetic disorder affecting 1 in 3,000 people. Through research conducted by the NF Research Program within the CDMRP, research at the National Institutes of Health (NIH), and other public and private research partnerships, we know we will find solutions for NF patients as well as 175 million Americans suffering from traumatic brain injury, cognitive delays, various cancers, persistent pain, nerve damage and amputations.

Please join us for a briefing in collaboration with the Littlest Tumor Foundation on the value of the CDMRP to finding treatments for NF and other deadly diseases.

Hill Happenings does not guarantee that these events conform to House, Senate, or Executive branch ethics requirements. Events posted here are in no way endorsed or sponsored by Hill Happenings. Events are posted for informational purposes only, admittance is not guaranteed.